Skip to main content
. 2020 Oct 7;20:729. doi: 10.1186/s12879-020-05437-1

Table 2.

Presenting clinical features of Pseudomonas aeruginosa bloodstream infection and site of infection

Variable Total
N = 91
n/N (%)
HAI
N = 60
n/N (%)
IPOA
N = 31
n/N (%)
P value
Presenting featuresa
Respiratory distress 34 (37.4) 23 (38.3) 11 (35.5) 0.487
Diarrhoea 29 (31.9) 16 (26.7) 13 (41.9) 0.107
Wound infection 23 (25.3) 18 (30.0) 5 (16.1) 0.116
Shock 13 (14.3) 4 (6.7) 9 (29.0) 0.009
Ecthyma gangrenosum 3 (3.3) 1 (1.7) 2 (6.5) 0.267
Otitis media 4 (4.4) 1 (1.7) 3 (9.7) 0.113
Otherb 7 (7.7) 3 (5.0) 4 (12.9) 0.224
Site of infection
No definable focus 18 (19.8) 12 (20.0) 6 (19.4) 1.000
Pneumonia 33 (36.3) 22 (36.7) 11 (35.5) 1.000
Gastrointestinal tractc 7 (7.7) 3 (5.0) 4 (12.9) 0.224
Skin & soft tissue infection 20 (22.0) 16 (26.7) 4 (12.9) 0.184
Line infection 8 (8.8) 6 (10.0) 2 (6.5) 0.711
Urosepsis 4 (4.4) 1 (1.7) 3 (9.7) 0.132

HAI Healthcare-associated infection, IPOA Infection present on admission; a, some patients presented with > 1 presenting feature; b, vomiting (2), renal angle tenderness (1), necrotising bowel (1), tachycardia (1), eye discharge (1), acute abdomen (1); c, gastroenteritis (4), acute appendicitis (1), acute peritonitis (2).

HHS Vulnerability Disclosure